Phosphorylation of the N-Formyl Peptide Receptor Is Required for Receptor Internalization but Not Chemotaxis*

  1. Matthew H. Hsu,
  2. Stephanie C. Chiang,
  3. Richard D. Ye and
  4. Eric R. Prossnitz
  1. From the Department of Immunology, The Scripps Research Institute, La Jolla, California 92037

    Abstract

    The human N-formyl peptide receptor (FPR) is a member of the family of leukocyte, G protein-coupled, chemoattractant receptors. To determine the role(s) of receptor phosphorylation in FPR processing and formylmethionylleucylphenylalanine (fMLF)-mediated chemotaxis, we utilized U937 cells expressing the recombinant wild type receptor and a mutant form of the FPR. This mutant, which lacks all of the serine and threonine residues in the C terminus of the receptor, ΔST, has recently been shown to produce a receptor capable of fMLF binding and G protein activation but was demonstrated not to undergo fMLF-dependent phosphorylation or desensitization of the calcium mobilization response upon repeated exposure to agonist (Prossnitz, E. R. (1997) J. Biol. Chem. 272, 15213–15219). In this report, we examined the role of receptor phosphorylation in FPR internalization and leukocyte chemotaxis. Whereas the wild type receptor was rapidly internalized upon stimulation, the phosphorylation-deficient mutant was not, remaining entirely on the cell surface. In addition, contrary to the hypothesis that receptor processing and recycling are required for chemotaxis, we found no defect in the ability of the mutant FPR to migrate up a concentration gradient of fMLF. These results indicate that phosphorylation of the FPR is a necessary step in receptor internalization but that receptor phosphorylation, desensitization, and internalization are not required for chemotaxis.

    Footnotes

    • * This research was supported by National Institutes of Health Grants AI36357 (to E. R. P.) and AI33503 (to R. D. Y.) and by a grant-in-aid from the American Heart Association (to E. R. P.). This is Publication 10987-IMM from the Department of Immunology, the Scripps Research Institute.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • To whom correspondence and reprint requests should be addressed: Dept. of Immunology, IMM25, The Scripps Research Inst., 10550 N. Torrey Pines Rd., La Jolla CA 92037. Tel.: 619-784-8549; Fax: 619-784-8476; E-mail: epross{at}scripps.edu.

    • 1 The abbreviations used are: G protein, guanine nucleotide-binding regulatory protein; FPR, N-formyl peptide receptor; Nle, norleucine; fMLF,N-formyl-methionyl-leucyl-phenylalanine; HBSS, Hanks’ buffered saline solution.

      • Received July 15, 1997.
      • Revision received September 22, 1997.
    « Previous | Next Article »Table of Contents
    • Advertisement
    • Advertisement
    Advertisement